A study of the patent microorganism mechanism for biological resource management = 생물자원 관리를 위한 특허미생물제도 연구

Abstract

Biotechnological patents are essential for the commercialization of biological products and the consolidation of bioindustry competition. With living organisms now being used as a source of invention, the biotechnological patent is differentiated from other patents in terms of its reproducibility. This is recognized in the ‘Budapest Treaty on the International Recognition of the Deposit of Microorganisms for the Purpose of Patent Procedure’. Based on this treaty, the microorganism intended for patenting is deposited to the International Deposit Authority (IDA) before patent application. There are currently 46 IDAs in operation around the world that can be used to make a valid biological material deposit for patent application. As of 2016, 102,035 strains of microorganism have been deposited to the IDA. In Korea, the Korean Agricultural Culture Collection (KACC), Korean Culture Center of Microorganisms (KCCM), Korean Cell Line Research Foundation (KCLRF), and Korean Culture Collection for Type Cultures (KCTC) all have IDA designation.